Harrow Health, Inc. (HROW) vs Replimune Group, Inc. (REPL)

A side-by-side comparison of Harrow Health, Inc. and Replimune Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HROW vs REPL

growth of $100 · dividends reinvested · last 8y
HROW +1195.8% (+37.7%/yr)REPL -13.3% (-1.8%/yr)HROW compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002020202220242026$1,296$87
HROW REPL

HROW vs REPL: by the numbers

  • •HROW is the larger company ($1.13B vs $1.09B market cap).
  • •Both run net losses; REPL's is the smaller (0.00% vs -13.51% net margin).

Metrics side by side

Valuation

MetricHROWREPL
P/S ratio4.09N/A
P/B ratio74.0810.35
FCF yield0.47%N/A

Profitability

MetricHROWREPL
Gross margin73.28%0.00%
Operating margin14.18%0.00%
Net margin-13.51%0.00%
ROE-244.91%-281.14%
ROIC1.81%-139.11%

Growth (annualized)

MetricHROWREPL
Revenue CAGR (5Y)34.52%N/A
Total return CAGR (5Y)27.66%-15.17%

Frequently asked

How have HROW and REPL total returns compared?
Over the past 5 years, HROW delivered 27.66% and REPL delivered -15.17% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.